MARC details
000 -LEADER |
fixed length control field |
03916nam a22004815i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231109085930.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220217s2022 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783030929381 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-030-92938-1 |
Source of number or code |
doi |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
TR-AnTOB |
Language of cataloging |
eng |
Transcribing agency |
TR-AnTOB |
Description conventions |
rda |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WR 205 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJK |
Source |
bicssc |
|
Subject category code |
MED017000 |
Source |
bisacsh |
|
Subject category code |
MJK |
Source |
thema |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
WR205EBK |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
245 10 - TITLE STATEMENT |
Title |
Biologic Therapy for Psoriasis |
Medium |
[electronic resource] : |
Remainder of title |
Cutting Edge Treatment Principles / |
Statement of responsibility, etc. |
edited by Nicholas Brownstone, Tina Bhutani, Wilson Liao. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
490 1# - SERIES STATEMENT |
Series statement |
Updates in Clinical Dermatology, |
International Standard Serial Number |
2523-8892 |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Introduction to Biologic Therapy for Psoriasis -- Laboratory Monitoring: TB, Hepatitis and HIV -- TNF-Alpha Class of Biologic Agents in Psoriatic Disease -- IL-17 class of Biologic Agents in Psoriatic Disease -- IL-23 Inhibition for the Treatment of Psoriatic Disease: Pathway Discovery and Overview -- Combination Therapy with Biologic Agents -- Biologic Agents for the Treatment of Pediatric Psoriasis -- Special Site Psoriasis -- Comparing Biologic Agents in Treatment of Psoriasis -- Long Term Registry Data for Psoriasis Biologics -- Psoriasis Biologic Agents in Special Populations -- Psoriasis Biologics and the COVID-19 Pandemic: Lessons Learned -- Adherence to Biologic Therapy for Psoriasis. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Biologic therapy is a treatment that strives to modulate a patient's immune system to fight a given disease. In psoriasis, a skin disorder that is partly caused by a dysregulated immune system resulting in well-demarcated red areas of the skin with white scales, biologic therapy has the potential to vastly improve upon patient outcomes by minimizing the symptoms of this disease while maximizing the safety profile of the therapy. This book offers an up-to-date and comprehensive review on biologic therapy for the treatment of psoriasis. With over 10 FDA approved biologic agents for psoriasis (with more in the pipeline), confusion exists among providers regarding which agent is best for a particular patient. Chapters cover all FDA approved psoriasis biologic agents (including pipeline agents) for use in pediatric, adult, and geriatric patients. This book is unique in that it will not only cover cutting edge treatment principles based on the latest research, it will also be one of the most comprehensive reviews of psoriasis biologics in the COVID-19 era. Biologic Therapy for Psoriasis is a must-have resource for board certified dermatologists and rheumatologists, dermatology and rheumatology residents and fellows, dermatology physician assistants, nurse practitioners and medical students. The ultimate goal of this book is to improve patient care by making the busy practicing dermatology provider more adept with these particular therapies. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Dermatology. |
|
Topical term or geographic name entry element |
Dermatology. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Brownstone, Nicholas. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
Personal name |
Bhutani, Tina. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
Personal name |
Liao, Wilson. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Updates in Clinical Dermatology, |
International Standard Serial Number |
2523-8892 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-92938-1">https://doi.org/10.1007/978-3-030-92938-1</a> |
Materials specified |
Springer eBooks |
Public note |
Online access link to the resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |